Ayurcann Holdings Corp Stock Performance
| AYURF Stock | USD 0.02 0.03 57.69% |
The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. Ayurcann Holdings returns are very sensitive to returns on the market. As the market goes up or down, Ayurcann Holdings is expected to follow. Ayurcann Holdings Corp right now shows a risk of 13.78%. Please confirm Ayurcann Holdings Corp value at risk, as well as the relationship between the skewness and day typical price , to decide if Ayurcann Holdings Corp will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ayurcann Holdings Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ayurcann Holdings is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 725 K | |
| Total Cashflows From Investing Activities | -262.6 K |
Ayurcann |
Ayurcann Holdings Relative Risk vs. Return Landscape
If you would invest 4.01 in Ayurcann Holdings Corp on August 25, 2024 and sell it today you would lose (1.81) from holding Ayurcann Holdings Corp or give up 45.14% of portfolio value over 90 days. Ayurcann Holdings Corp is currently producing 0.0945% returns and takes up 13.7823% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Ayurcann, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ayurcann Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ayurcann Holdings' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Ayurcann Holdings Corp, and traders can use it to determine the average amount a Ayurcann Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0069
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | AYURF |
| Negative Returns |
Estimated Market Risk
| 13.78 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ayurcann Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ayurcann Holdings by adding Ayurcann Holdings to a well-diversified portfolio.
Ayurcann Holdings Fundamentals Growth
Ayurcann OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Ayurcann Holdings, and Ayurcann Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ayurcann OTC Stock performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.46) % | |||
| Current Valuation | 4.62 M | |||
| Shares Outstanding | 155.56 M | |||
| Price To Earning | 4.70 X | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 11.08 M | |||
| EBITDA | (1.32 M) | |||
| Cash And Equivalents | 1.24 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (50.09 K) | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 7.28 M | |||
About Ayurcann Holdings Performance
By analyzing Ayurcann Holdings' fundamental ratios, stakeholders can gain valuable insights into Ayurcann Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ayurcann Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ayurcann Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company was founded in 2018 and is headquartered in Pickering, Canada. Ayurcann Hldgs is traded on OTC Exchange in the United States.Things to note about Ayurcann Holdings Corp performance evaluation
Checking the ongoing alerts about Ayurcann Holdings for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Ayurcann Holdings Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ayurcann Holdings had very high historical volatility over the last 90 days | |
| Ayurcann Holdings has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 11.08 M. Net Loss for the year was (3.09 M) with profit before overhead, payroll, taxes, and interest of 2.22 M. | |
| Ayurcann Holdings Corp has accumulated about 1.24 M in cash with (50.09 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 73.0% of the company shares are held by company insiders |
- Analyzing Ayurcann Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ayurcann Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Ayurcann Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ayurcann Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ayurcann Holdings' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Ayurcann Holdings' otc stock. These opinions can provide insight into Ayurcann Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ayurcann OTC Stock analysis
When running Ayurcann Holdings' price analysis, check to measure Ayurcann Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ayurcann Holdings is operating at the current time. Most of Ayurcann Holdings' value examination focuses on studying past and present price action to predict the probability of Ayurcann Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ayurcann Holdings' price. Additionally, you may evaluate how the addition of Ayurcann Holdings to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |